• With $9.5M, Intrepida Bio Launches to Target Pancreatic Cancer & More

    8 days ago - By San Diego Biotechnology

    Dauntless Pharmaceuticals formed in 2016, and its founders said the Sofinnova Ventures-backed firm planned to take a new approach to building biotechs. Instead of advancing a broad stable of early-stage drug candidates under the same roof, Dauntless ai......
    Read more ...